Supriya Lifescience Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

729.80

-34.85 (-4.56%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

729.80

-34.85 (-4.56%)
16:02 Dec 20

Quality

86/100
High Financial Strength

Valuation

31/100
Mid Valuation

Technical

67/100
Technically Moderately Bullish

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM 2024
Net Sales	385.37	530.05	460.94	570.37	624.98
Operating Expenses +	218.07	316.06	332.04	397.4	400.7
Raw Material	140.57	198.83	187.32	191.43	210.51
Increase Decrease in Cost	-12.44	-3.02	-6.51	30.31	-3.06
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	32.76	49.08	55.58	67.64	74.46
Miscellaneous Expenses	57.18	71.17	95.65	108.02	118.79
Operating Profit	167.3	213.99	128.9	172.97	224.28
Other Income	10.86	7.58	9.49	10.64	9.98
Depreciation	6.76	10.12	11.82	15.81	17.27
Interest	4.08	4.2	3.08	2.11	1.86
Profit before tax and exceptio..	167.31	207.24	123.49	165.69	215.13
Exceptional Items	0	0	0	0	0
PBT	167.31	207.24	123.49	165.69	215.13
Provision for Taxation	43.72	55.44	33.63	46.58	57.6
Net Profit	123.59	151.81	89.86	119.11	157.51
NET Profit after MI	0	0	0	0	0
EPS	16.89	18.86	11.16	14.8	19.54
Operating Profit Margin (%)	43.41	40.37	27.96	30.33	35.89
Net Profit Margin (%)	32.07	28.64	19.49	20.88	25.2

ShareHolding

All Data in Percentage (%)

	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23
Promoter	68.30	68.30	68.30	68.30	68.30
FII	6.00	5.00	5.40	4.60	5.40
MF	0.60	0.10	0.00	0.00	1.70
Public	20.20	21.30	21.00	21.80	19.20
Others	0.00	0.00	0.00	0.00	0.00
Others	4.90	5.30	5.30	5.30	5.40